Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

1. Puyalto, A.
2. Rodríguez-Remírez, M.
3. López, I.
4. Macaya, I.
5. Guruceaga, E.
6. Olmedo, M.
7. Vilalta-Lacarra, A.
8. Welch, C.
9. Sandiego, S.
10. Vicent, S.
11. Valencia, K.
12. Calvo, A.
13. Pio, R.
14. Raez, L.E.
15. Rolfo, C.
16. Ajona, D.
17. Gil-Bazo, I.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1186/S12943-024-01991-3 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus